☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Non-Metastatic Castration
Bayer's Nubeqa (darolutamide) Receives the US FDA's Approval for Non-Metastatic Castration-Resistant Prostate Cancer in Men
July 31, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.